Role of Genomics and Epigenetics in Toxicology
Genomics and epigenetics are increasingly recognized as critical factors influencing individual responses to toxicants and drugs. These fields explore how genetic variations and heritable changes in gene expression without DNA sequence alteration impact susceptibility to adverse effects and toxicological mechanisms.
Genomic studies involve analyzing single nucleotide polymorphisms (SNPs), copy number variations, and gene expression profiles that may modify metabolic pathways, transporters, or receptors involved in xenobiotic processing. Such variations can alter drug metabolism, leading to differences in toxicity among populations.
Epigenetic modifications—including DNA methylation, histone modifications, and non-coding RNAs—regulate gene expression in response to environmental exposures. Toxicants may induce epigenetic changes that contribute to carcinogenesis, developmental defects, or long-term health consequences.
Integration of genomics and epigenetics in toxicology supports identification of biomarkers for susceptibility, mechanism elucidation, and personalized risk assessment. Advances in next-generation sequencing and bioinformatics facilitate comprehensive analyses, enhancing predictive toxicology.
Understanding these molecular layers aids in developing safer drugs and tailoring therapies to minimize toxic risks in diverse patient groups.